188 related articles for article (PubMed ID: 19073742)
21. Treatment of human immunodeficiency virus type 1 virions depleted of cyclophilin A by natural endogenous reverse transcription restores infectivity.
Khan M; Garcia-Barrio M; Powell MD
J Virol; 2003 Apr; 77(7):4431-4. PubMed ID: 12634401
[TBL] [Abstract][Full Text] [Related]
22. Cyclophilin A protects HIV-1 from restriction by human TRIM5α.
Kim K; Dauphin A; Komurlu S; McCauley SM; Yurkovetskiy L; Carbone C; Diehl WE; Strambio-De-Castillia C; Campbell EM; Luban J
Nat Microbiol; 2019 Dec; 4(12):2044-2051. PubMed ID: 31636416
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.
Schaller T; Ocwieja KE; Rasaiyaah J; Price AJ; Brady TL; Roth SL; Hué S; Fletcher AJ; Lee K; KewalRamani VN; Noursadeghi M; Jenner RG; James LC; Bushman FD; Towers GJ
PLoS Pathog; 2011 Dec; 7(12):e1002439. PubMed ID: 22174692
[TBL] [Abstract][Full Text] [Related]
24. trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activity.
Saphire AC; Bobardt MD; Gallay PA
J Virol; 2002 Mar; 76(5):2255-62. PubMed ID: 11836403
[TBL] [Abstract][Full Text] [Related]
25. Identification of capsid mutations that alter the rate of HIV-1 uncoating in infected cells.
Hulme AE; Kelley Z; Okocha EA; Hope TJ
J Virol; 2015 Jan; 89(1):643-51. PubMed ID: 25339776
[TBL] [Abstract][Full Text] [Related]
26. Cyclophilin A potentiates TRIM5α inhibition of HIV-1 nuclear import without promoting TRIM5α binding to the viral capsid.
Burse M; Shi J; Aiken C
PLoS One; 2017; 12(8):e0182298. PubMed ID: 28767697
[TBL] [Abstract][Full Text] [Related]
27. Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type.
Matsuoka S; Dam E; Lecossier D; Clavel F; Hance AJ
Retrovirology; 2009 Mar; 6():21. PubMed ID: 19254360
[TBL] [Abstract][Full Text] [Related]
28. Characterization of HIV-1 uncoating in human microglial cell lines.
Ingram Z; Taylor M; Okland G; Martin R; Hulme AE
Virol J; 2020 Mar; 17(1):31. PubMed ID: 32143686
[TBL] [Abstract][Full Text] [Related]
29. Contribution of glutamine residues in the helix 4-5 loop to capsid-capsid interactions in simian immunodeficiency virus of macaques.
Tipper C; Sodroski JG
J Virol; 2014 Sep; 88(18):10289-302. PubMed ID: 24991000
[TBL] [Abstract][Full Text] [Related]
30. Efficient transduction of simian cells by HIV-1-based lentiviral vectors that contain mutations in the capsid protein.
Rits MA; van Dort KA; Münk C; Meijer AB; Kootstra NA
Mol Ther; 2007 May; 15(5):930-7. PubMed ID: 17299408
[TBL] [Abstract][Full Text] [Related]
31. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
[TBL] [Abstract][Full Text] [Related]
32. Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid.
Wiegers K; Rutter G; Schubert U; Grättinger M; Kräusslich HG
Virology; 1999 Apr; 257(1):261-74. PubMed ID: 10208939
[TBL] [Abstract][Full Text] [Related]
33. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.
Brockman MA; Schneidewind A; Lahaie M; Schmidt A; Miura T; Desouza I; Ryvkin F; Derdeyn CA; Allen S; Hunter E; Mulenga J; Goepfert PA; Walker BD; Allen TM
J Virol; 2007 Nov; 81(22):12608-18. PubMed ID: 17728232
[TBL] [Abstract][Full Text] [Related]
34. Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells.
Chatterji U; Bobardt MD; Stanfield R; Ptak RG; Pallansch LA; Ward PA; Jones MJ; Stoddart CA; Scalfaro P; Dumont JM; Besseghir K; Rosenwirth B; Gallay PA
J Biol Chem; 2005 Dec; 280(48):40293-300. PubMed ID: 16199531
[TBL] [Abstract][Full Text] [Related]
35. SUN1 Regulates HIV-1 Nuclear Import in a Manner Dependent on the Interaction between the Viral Capsid and Cellular Cyclophilin A.
Luo X; Yang W; Gao G
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643244
[TBL] [Abstract][Full Text] [Related]
36. Cyclophilin A interacts with diverse lentiviral capsids.
Lin TY; Emerman M
Retrovirology; 2006 Oct; 3():70. PubMed ID: 17038183
[TBL] [Abstract][Full Text] [Related]
37. Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core.
Briones MS; Dobard CW; Chow SA
J Virol; 2010 May; 84(10):5181-90. PubMed ID: 20219923
[TBL] [Abstract][Full Text] [Related]
38. Fusion of cyclophilin A to Fv1 enables cyclosporine-sensitive restriction of human and feline immunodeficiency viruses.
Schaller T; Ylinen LM; Webb BL; Singh S; Towers GJ
J Virol; 2007 Sep; 81(18):10055-63. PubMed ID: 17609268
[TBL] [Abstract][Full Text] [Related]
39. Cyclophilin A stabilizes the HIV-1 capsid through a novel non-canonical binding site.
Liu C; Perilla JR; Ning J; Lu M; Hou G; Ramalho R; Himes BA; Zhao G; Bedwell GJ; Byeon IJ; Ahn J; Gronenborn AM; Prevelige PE; Rousso I; Aiken C; Polenova T; Schulten K; Zhang P
Nat Commun; 2016 Mar; 7():10714. PubMed ID: 26940118
[TBL] [Abstract][Full Text] [Related]
40. The cyclophilin A-binding loop of the capsid regulates the human TRIM5α sensitivity of nonpandemic HIV-1.
Twizerimana AP; Becker D; Zhu S; Luedde T; Gohlke H; Münk C
Proc Natl Acad Sci U S A; 2023 Nov; 120(48):e2306374120. PubMed ID: 37983491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
